Cancer that forms in the tissues of the colon (the longest part of the large intestine). Most colon cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids). An estimated 106,000 cases of colon cancer are diagnosed in the United States each year.
For more information, visit the National Cancer Institute.
Treatment at the UAB Comprehensive Cancer Center
Colon cancer patients at the UAB Comprehensive Cancer Center are seen in the center’s Multidisciplinary Gastrointestinal Oncology Clinic, located in The Kirklin Clinic of UAB Hospital. The clinic treats all types of GI cancers, including esophageal cancer, stomach cancer, liver cancer, pancreatic cancer, bile duct cancer, colon cancer and rectal cancer, as well as soft-tissue sarcomas and endocrine diseases (thyroid, parathyroid, pancreas and adrenal).
The clinic’s multidisciplinary approach to treatment provides access to a team of dedicated specialists, including medical oncologists, radiation oncologists, surgical oncologists and radiologists, who work together to design the most effective treatment plan possible.
Gastrointestinal Oncology Multidisciplinary Clinic:
The Kirklin Clinic of UAB Hospital
2000 6th Avenue South
Birmingham, AL 35233
Colon Cancer Research at the UAB Comprehensive Cancer Center
The UAB Comprehensive Cancer Center is a nationally recognized leader in the research and treatment of colon cancer. The center played an integral role in the development and approval of two important drugs used to treat colon cancer – Avastin and Erbitux, the latter of which was the first monoclonal antibody approved by the FDA for the treatment of colon cancer.
The Cancer Center also researches minimally invasive surgical techniques, including laparascopic procedures, in order to improve patient comfort and recovery.